A lasting legacy: USask shines as a nuclear research hub

In 1951, the University of Saskatchewan (USask) changed the face of nuclear medicine forever.

Nicknamed the “cancer bomb,” Dr. Harold Johns (PhD) and a team of then-graduate students that included the renowned Sylvia Fedoruk pioneered a cancer treatment using cobalt-60 radiation therapy.  

At a time when traditional cancer treatments were just starting to enter the realm of nuclear medicine, the cobalt-60 therapy was a gamechanger. A true breakthrough in nuclear technology and innovation, the cobalt-60 treatment spread quickly and is responsible for helping thousands of cancer patients around the world. Its ingenuity and originality also put USask’s research on the map.  

You can read the full article here.